LLY
62
-2
BIIB
52
-4
WM
50
-4
DLTR
64
-2
OXY
32
-5
DHI
33
-6
BRK.B
40
-3
MU
66
11
AVY
47
-3
MTCH
60
-6
EIX
45
-8
FTI
64
-15
EXPD
37
-3
IP
34
-5
SIG
47
3
EOG
54
9
CLX
50
-3
TRIP
57
-3
DE
42
-3
ZBH
45
-2
LLY
62
-2
BIIB
52
-4
WM
50
-4
DLTR
64
-2
OXY
32
-5
DHI
33
-6
BRK.B
40
-3
MU
66
11
AVY
47
-3
MTCH
60
-6
EIX
45
-8
FTI
64
-15
EXPD
37
-3
IP
34
-5
SIG
47
3
EOG
54
9
CLX
50
-3
TRIP
57
-3
DE
42
-3
ZBH
45
-2
Financhill
Back

ProShares S&P Kensho Cleantech ETF Vs. Kymera Therapeutics, Inc. Sector Stock Comparison

Buy
56

CTEX
ProShares S&P Kensho Cleantech ETF

Last Price:
$37.32
Seasonality Move:
-6.55%
Buy
90

KYMR
Kymera Therapeutics, Inc.

Last Price:
$94.38
Seasonality Move:
7.7%
Buy
56
ProShares S&P Kensho Cleantech ETF (CTEX) is a Buy

Is ProShares S&P Kensho Cleantech ETF a Buy, Sell or Hold?

  • The current ProShares S&P Kensho Cleantech ETF [CTEX] share price is $36.76. The Score for CTEX is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
  • CTEX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
90
Kymera Therapeutics, Inc. (KYMR) is a Buy

Is Kymera Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Kymera Therapeutics, Inc. [KYMR] share price is $94.30. The Score for KYMR is 90, which is 80% above its historic median score of 50, and infers lower risk than normal.
  • KYMR is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.

CTEX Stock Price Chart

What is ProShares S&P Kensho Cleantech ETF's stock price today?

  • The ProShares S&P Kensho Cleantech ETF share price today is $36.76
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CTEX is experiencing slight selling pressure.

KYMR Stock Price Chart

What is Kymera Therapeutics, Inc.'s stock price today?

  • The Kymera Therapeutics, Inc. share price today is $94.30
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KYMR is experiencing slight selling pressure.

CTEX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.24 Buy
Relative Strength Index (14 RSI): 56.17 Buy
Chaikin Money Flow: -488 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (33.63 - 38.09) Buy
Bollinger Bands (100): (25.64 - 35.86) Buy

KYMR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 3.92 Buy
Relative Strength Index (14 RSI): 86.88 Buy
Chaikin Money Flow: -462379 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (58.8 - 71.72) Buy
Bollinger Bands (100): (43.38 - 63.26) Buy

CTEX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 35.81 Buy
20-day SMA: 35.31 Buy
50-day SMA: 35.36 Buy
200-day SMA: 25.05 Buy
8-day EMA: 35.86 Buy
20-day EMA: 35.49 Buy
50-day EMA: 33.77 Buy
200-day EMA: 19.51 Buy

KYMR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 70 Buy
20-day SMA: 66.61 Buy
50-day SMA: 61.97 Buy
200-day SMA: 44.25 Buy
8-day EMA: 72.36 Buy
20-day EMA: 67.57 Buy
50-day EMA: 61.93 Buy
200-day EMA: 49.42 Buy

ProShares S&P Kensho Cleantech ETF Earnings Growth & CTEX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Kymera Therapeutics, Inc. Earnings Growth & KYMR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.17 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.64 per share, and a decrease next year of $0.35 per share.

ProShares S&P Kensho Cleantech ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Kymera Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):